Home » Immunization News » The Shingles Vaccine Shortage

The Shingles Vaccine Shortage

Shingrix became the second shingles vaccine to be licensed in the United States, becoming the preferred shingles vaccine in 2017.

“Shingrix provides strong protection against shingles and PHN. Two doses of Shingrix is more than 90% effective at preventing shingles and PHN. Protection stays above 85% for at least the first four years after you get vaccinated.”

What Everyone Should Know about Shingles Vaccine

The first, Zostavax, was licensed in 2006.

Both are for older adults.

The Shingles Vaccine Shortage

Having a new and better shingles vaccine is good!

High levels of demand for shingles vaccine has lead to shortages and Shingrix manufacturing facilities are already at maximum capacity.
High levels of demand for shingles vaccine has lead to shortages and Shingrix manufacturing facilities are already at maximum capacity.

Not being able to actually get the vaccine and get vaccinated and protected isn’t so good. There has been a shortage of the vaccine due to high levels of demand since last year.

“Recombinant zoster vaccine (RZV) is recommended for the prevention of herpes zoster and related complications for immunocompetent adults aged ≥50 years.”

Recommendations of the Advisory Committee on Immunization Practices for Use of Herpes Zoster Vaccines

Fortunately, we will likely see more doses of the vaccine available this year and everyone will eventually be able to get vaccinated. In addition to your doctor or favorite pharmacy, the Shingrix Vaccine Locator might help you find a dose until the shortage is over.

More on the Shingles Vaccine Shortage

Last Updated on April 6, 2024

Discover more from VAXOPEDIA

Subscribe now to keep reading and get access to the full archive.

Continue reading